Optimization of Nutritional State on the Outcome of Patients with Acute Exacerbation of Bronchiectasis
Impact of Optimization of Nutritional State on the Outcome of Patients with Acute Exacerbation of Bronchiectasis
Bronchiectasis is a chronic respiratory condition characterized by the abnormal and permanent dilation of the bronchi, leading to recurrent respiratory infections, chronic cough, and significant morbidity. The disease has gained increasing recognition due to its rising prevalence and the substantial burden it places on healthcare systems .
Recent studies have highlighted the importance of nutritional status in managing chronic respiratory diseases, including bronchiectasis. Malnutrition is prevalent among patients with bronchiectasis, particularly those experiencing frequent exacerbations. It has been shown that underweight patients have lower lung function and may face worse clinical outcomes compared to those with normal weight . Specifically, a study found that underweight individuals had a significantly lower forced expiratory volume in one second (FEV1) compared to their normal-weight counterparts, indicating a direct correlation between nutritional status and respiratory function .
Study Overview
Status
Conditions
Detailed Description
To evaluate the effects of nutritional optimization on clinical outcomes in patients experiencing an acute exacerbation of bronchiectasis. Specifically, the study seeks to:
Assess the Relationship Between Nutritional Status and Clinical Outcomes*: To investigate how improvements in nutritional status, measured through dietary intake, body weight, and biochemical markers, correlate with clinical outcomes such as length of hospital stay, frequency of exacerbations, and overall recovery.
- *Evaluate the Effectiveness of Nutritional Interventions*: To determine the impact of specific nutritional interventions (e.g., high-protein diets, caloric supplementation, and micronutrient support) on the health status and recovery of patients during acute exacerbations.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Hend Mohamed Sayed, Doctor
- Phone Number: 01098988712
- Email: hend.m.saleh@gmail.com
Study Contact Backup
- Name: Ahmed mohamed Shadad, Doctor
- Phone Number: 0111117930
- Email: Shaddad_ahmad@aun.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Recruitment Patients will be recruited from inpatient wards. Informed consent will be obtained from all participants prior to enrollment.
Nutritional Assessment
- **Baseline Assessment**:
- Nutritional status will be determined using the Subjective Global Assessment (SGA) and biochemical markers (e.g., serum albumin).
- Dietary intake will be assessed using a 3-day food diary or 24-hour dietary recall method.
- **Nutritional Optimization**: Patients identified as malnourished will receive a tailored nutritional intervention, which may include:
- High-protein dietary recommendations.
- Caloric supplementation through protein shakes or high-calorie snacks.
- Micronutrient supplementation as need
Data Collection
Data will be collected at three time points:
- **Baseline**: Upon admission.
- **During Hospitalization**: After the implementation of nutritional interventions.
- **Follow-Up**: Six months post-discharge, assessing long-term outcomes.
Description
Inclusion Criteria:
*Age*: Adults aged 18 years and older.
- Diagnosis*: Confirmed diagnosis of bronchiectasis, as established by clinical evaluation and imaging studies (e.g., chest CT scan).
- Acute Exacerbation*: Patients presenting with acute exacerbation symptoms, such as increased sputum production, worsening dyspnea, or chest pain.
- Nutritional Assessment*: Patients identified as malnourished or at risk of malnutrition based on the Subjective Global Assessment (SGA) or similar nutritional screening tools.
Exclusion Criteria:
*Cognitive Impairment*: Patients with cognitive impairments that affect their ability to participate in the study or adhere to nutritional recommendations.
- Current Enteral Feeding*: Patients receiving enteral nutrition or those with a feeding tube.
Recent Nutritional Interventions*: Patients who have recently undergone significant nutritional interventions (e.g., dietary changes, supplementation) within the past three months prior to enrollment.
*Pregnancy or Lactation*: Pregnant or lactating women, due to the need for specific nutritional considerations.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Asses The Change In Quality of life
Time Frame: base line
|
measured by the St. George's Respiratory Questionnaire (SGRQ).
|
base line
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Bronchiectas nutritional state
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.